Status:
COMPLETED
Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Patty Brisben Foundation For Women's Sexual Health
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.
Detailed Description
The purpose of this research is to study the effectiveness of an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer. The aim is to de...
Eligibility Criteria
Inclusion
- Women diagnosed with Stage1-IV ovarian cancer
- Prognosis of at least one year to live (as assessed by provider)
- Endorsement of at least one sexual symptom (see Appendix A for eligibility screening)
- English speaking
- Signed informed consent
Exclusion
- History of pelvic radiation
- Cognitive impairment which would interfere with the ability to participate in the study (as assessed by provider)
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT02287519
Start Date
November 1 2014
End Date
December 1 2019
Last Update
February 28 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115